ZEVRA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Zevra Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • Zevra Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 54.8M shares, a 45% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 54.8M +17M +45% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 43.6M +8.06M +22.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 43.4M +7.97M +22.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 43.1M +7.66M +21.6% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 37.8M +2.38M +6.71% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 35.5M +104K +0.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 35.5M +124K +0.35% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 35.5M +124K +0.35% Dec 31, 2022 10-K 2024-04-01
Q3 2022 35.4M +93.8K +0.27% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 35.4M +421K +1.21% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 35.3M +6.85M +24.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 35.3M +30.8M +679% Dec 31, 2021 10-K 2023-03-07
Q3 2021 35.3M -37.2M -51.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 35M -32.2M -48% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 28.5M -28.3M -49.8% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 4.54M +2.27M +99.7% Dec 31, 2020 10-K 2022-03-31
Q3 2020 72.5M +40.1M +124% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 67.2M +38.4M +133% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 56.8M +28.8M +103% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 2.27M -24.2M -91.4% Dec 31, 2019 10-K 2021-03-12
Q3 2019 32.4M +16.3M +102% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 28.9M +13M +81.4% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 28M +12.9M +85.2% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 26.5M +11.8M +80.5% Dec 31, 2018 10-K 2020-02-28
Q3 2018 16M +1.38M +9.45% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 15.9M +1.25M +8.51% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 15.1M +458K +3.13% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 14.7M +10.4K +0.07% Dec 31, 2017 10-K 2019-03-01
Q3 2017 14.7M +10.4K +0.07% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 14.7M +10.4K +0.07% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 14.6M +148K +1.02% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 14.6M +156K +1.08% Dec 31, 2016 10-K 2018-03-30
Q3 2016 14.6M +405K +2.85% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 14.6M +419K +2.94% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 14.5M +12.1M +506% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 14.5M +12.1M +509% Dec 31, 2015 10-K 2017-03-10
Q3 2015 14.2M Sep 30, 2015 10-Q 2015-11-13
Q2 2015 14.2M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 2.39M Mar 31, 2015 10-Q 2015-05-29
Q4 2014 2.38M Dec 31, 2014 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.